Verastem Oncology (VSTM) Misses Q1 EPS by 43c

Verastem Oncology (NASDAQ: VSTM) reported Q1 EPS of ($0.43). Revenue for the quarter came in at $18.67 million.

For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Apollo Private Credit Fund caps redemptions at 5% - Bloomberg
• Avis Budget Group reaches $650M settlement with Pentwater Capital